Flurazepam Monohydrochloride is a long-acting benzodiazepine derivative indicated for the treatment of insomnia and other sleep disorders by modulating GABA receptors to produce sedative-hypnotic effects.… Read more
Flurazepam Monohydrochloride is a long-acting benzodiazepine derivative indicated for the treatment of insomnia and other sleep disorders by modulating GABA receptors to produce sedative-hypnotic effects. This category contains essential reference standards for the active pharmaceutical ingredient, as well as critical impurities, such as Flurazepam Monohydrochloride Impurity A, and related metabolites required for comprehensive pharmaceutical analysis. These compounds are vital for pharmaceutical laboratories conducting rigorous impurity profiling and quality control testing to ensure drug safety and efficacy. Additionally, stable isotope-labelled versions are available for use as internal standards, which are fundamental for achieving accurate quantification and reliable results during method development and validation. Utilizing high-quality reference materials allows analysts to effectively identify, monitor, and control potential degradation products and process-related impurities throughout the manufacturing lifecycle.